Skip to content
healthcare.dev
Get a free key

Migraine Relief

NDC 57344-205, ACETAMINOPHEN, ASPIRIN and CAFFEINE, tablet, from AAA PHARMACEUTICAL, INC..

Product NDC
57344-205
Status
Listed
Labeler
AAA PHARMACEUTICAL, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA214039
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57344-205 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN250 mg/1
  • ASPIRIN250 mg/1
  • CAFFEINE65 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
57344-205-01573440205011 BOTTLE, PLASTIC in 1 CARTON (57344-205-01) / 24 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 57344-205 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57344-205 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57344-205. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.